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 R e s e a R c h  a R t i c l e
Motion Sickness Lessons from the Southern Ocean
stephane Besnard; Jerome Bois; Martin hitier; Jeanne Vogt; Paul laforet; John F. Golding
 BACKGROUND: the objectives were to assess the prevalence, severity, and medication taken, and to look for predictive factors, in order 
to better identify characteristics of passengers at risk of motion sickness during transport from hobart in tasmania to 
the French polar stations in antarctica.
 METHODS: there were 239 passengers who were surveyed over 4 yr with 4 round trips per year using the Motion sickness 
susceptibility Questionnaire (MssQ), simulator sickness Questionnaire (ssQ), state-trait anxiety test (stai-trait and stai-
state), and general parameters (age, gender, number of trips, jet-lag, direction of the trip), medication, calculation of the 
distance of each passenger’s cabin to the centre of Gravity (coG.).
 RESULTS: While the passengers had a low intrinsic sensitivity to motion sickness (MssQ), 94% reported at least one ssQ symptom 
of motion sickness, and 38% vomited. Five associated factors were discovered: greater initial sensitivity (MssQ), 
anticipation of being ill, younger age, higher level of anxiety at midtrip, and greater distance from the coG. Of the 
passengers, there were 54% who took anti-motion sickness medication at different times of the trip, however, these 
passengers experienced more nausea. this could be due to self-selection since they were more sensitive to motion 
sickness.
 CONCLUSION: We identified three predictive factors of motion sickness (greater intrinsic susceptibility, younger age, and greater cabin 
distance from the coG). For preventive purposes, two associated factors of Ms (anticipation of being ill, MssQ score) 
were determined to classify three groups of risk of Ms to improve passenger care during the trip.
 KEYWORDS: seasickness, motion sickness, ssQ, boat, survey, MssQ, anxiety, anti-motion sickness drugs, habituation, cabin position.
Besnard S, Bois J, Hitier M, Vogt J, Laforet P, Golding JF. Motion sickness lessons from the Southern Ocean. Aerosp Med Hum Perform. 2021; 
92(9):1–8.
Motion sickness is a well-known malady that has been reported since antiquity.19 Its occurrence in a family and leisure context can be reduced by avoiding or 
stopping transportation. However, in an often unavoidable pro-
fessional context, motion sickness can prove to be very dis-
abling from a functional point of view, reducing performance of 
the personnel on board,24 and inducing some risks from a med-
ical perspective (dehydration, confusion, anxiety or panic 
attacks). The search for predictive factors to better screen sub-
jects at risk remains a challenge to be solved, particularly for 
maritime professionals, including the military. The Motion 
Sickness Susceptibility Questionnaire (MSSQ) which measures 
individual differences in susceptibility is a useful predictive 
marker of seasickness25 as well as of parabolic flight related 
space sickness.5 Others factors like young age, female gender, 
vestibular pathology, and ethnic origin may also be considered 
as global predictive/susceptibility factors.8,9,10 The Astrolabe is 
an oceanographic research vessel used to transport scientists 
and supply equipment to the Dumont d’Urville polar base, and 
then serves as a relay ship to other polar bases, including Con-
cordia. This ship is particularly at risk of motion sickness due to 
its flat bottom design to allow ice crossing, relatively moderate 
size of 66 m in length for Antarctica conditions, and with a 
North-South direction of travel continuously across very rough 
seas. The passengers, mostly scientists going to bases, also have 
little or no previous seafaring experience, and their journey is 
often their first maritime travel of several days.
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The Sickvest Project was selected by the French Polar 
Institute Paul Emile Victor to quantify the prevalence, medica-
tion on board, and the consequences of motion sickness for 
operational and passenger safety purposes. The second objec-
tive aimed to better identify people at risk and to propose rec-
ommendations to reduce this disabling syndrome onboard. 
Here we report the study which included 239 passengers sur-
veyed before and during each sea voyage.
METHODS
The Sickvest Project, sponsored by IPEV (French Polar Insti-
tute Paul Émile Victor) and started in 2014, was an observa-
tional survey conducted on board the vessel Astrolabe. This is a 
flat-bottomed ship carrying 48 passengers in 13 cabins. It is 66 
m long and 12.80 m wide with a 4.80-m draft. The Astrolabe is 
equipped with 13 passenger cabins: the 4 cabins closest to the 
center of gravity (less than 6 m away), the 4 intermediate cabins 
(between 6 and 10 m), and the 5 cabins farthest away (more 
than 10 m) can be grouped together. Four round trips per year 
are organized during the Austral summer to carry scientists 
from Hobart in Tasmania to the Dumont D’Urville station in 
Antarctica and return (Fig. 1). Passengers staying in Antarctica 
come and go back mainly by boat on the Astrolabe. However, 
some arrive by plane and leave by boat or vice versa. In the same 
way some stay on base for a few months to a year. Consequently, 
some of the passengers make two crossings with a delay between 
the inbound and outbound journeys, depending on the time 
they have to work in Antarctica; some of them did in and out-
bound trips while others only outbound journeys, if they came 
by plane first. For reasons of inclusion in the on-site study and 
anonymity, we cannot combine the round trips of the same pas-
sengers, so that we asked for the number of trips already done 
in the year or during previous campaigns.
Subjects
This study was approved by the Ethical Committee agreement 
NORTH WEST III (A14-D53-VOL. 22) and was registered on 
ClinicalTrials.gov. Each investigator on board was also the doc-
tor aboard ship. Participation in the study was offered to all 
Astrolabe passengers and crews during the security briefing 
upon arrival on the boat. They were given a video of approxi-
mately 15 min to describe the study. Volunteer subjects were 
between the ages of 18 and 70 who had received their medical 
fitness to travel to Adélie Land or to carry out a campaign 
oceanographic research aboard the Astrolabe. The sample in 
this study was composed of 239 subjects whose general charac-
teristics are summarized in Table I.
Procedures
The data collection was by a booklet of 20 pages, in which 
subjects were asked to answer several questionnaires on dif-
ferent neuropsychological components and all responses were 
anonymous (see Fig. 1). The booklet included various ques-
tions and questionnaires. The signed consent sheet was 
detached from the main booklet upon arrival on the boat. 
Questions were asked about the general characteristics of the 
subjects (age, sex, height, weight, medical history, usual med-
ical treatments, cabin and berth numbers, how they felt about 
Fig. 1. Protocol during the trip: MSSQ (Motion Sickness Susceptibility questionnaire), SSQ (Simulator Sickness Questionnaire), Anxiety measured with STAI 
questionnaire (STAI-trait and STAI-State), general parameters (age, gender, cabin and berth positions, any medical treatments).
Table I. General Characteristics of the Sample: Means (SD) or Percentages 
(N = 239).
VARIABLE MEAN (± SD) or %
Age (yr) 40.7 ± 12.1, range 20–74
Gender (M and F) 77% M ; 23% F
Any Motion Sickness Symptom  
(at Least 1 Item of the SSQ)
94%
Nausea at Some Point 69%
Vomited at Some Point 38%
Anti-MS Drug Treatment 54%
MSSQ Part A 5.2 ± 4.9
MSSQ Part B 4.1 ± 4.3
MSSQ Total Score 9.3 ± 8.4
MSSQ Percentile 37.4 ± 28.3
Past trips (Number) 0.13 ± 0.34
Anxiety Trait Baseline 33.1 ± 7.2
Anxiety Begin 28.8 ± 8.8
Anxiety Midtrip 29.4 ± 8.2
Anxiety End 25.7 ± 6.1
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their risk of motion sickness symptoms during travel, past 
trips). The Motion Sickness Susceptibility Questionnaire 
(MSSQ)7 was used as translated into French and validated for 
French language.18 This questionnaire has two parts: experi-
ences with motion sickness in childhood and as an adult in 
the last 10 yr. The Spielberger’s anxiety questionnaires21 were 
also employed: STAI-trait anxiety, to be completed upon 
arrival on the boat and STAI-state anxiety at the time of mea-
surement, to be completed on the 1st day, midway through the 
trip, and on the last day of the crossing. The Simulator Sick-
ness Questionnaire (SSQ) in French was completed daily to 
assess symptoms related to motion sickness. It consists of 16 
items (including nausea, vomiting, asthenia, pallor, vertigo, 
belching, etc.) with values from 0 to 3 depending on their 
intensity.15 The SSQ was our primary measure of overall 
degree of motion sickness. The SSQ of Kennedy et al.15 is one 
of the most widely used symptom checklists for motion sick-
ness. The SSQ includes other items apart from nausea, stom-
ach awareness, sweating, etc., that are relevant to motion 
sickness in general. Symptoms such as fatigue (Sopite), head-
ache, dizziness, vertigo, etc., are widely accepted motion sick-
ness symptoms. They will occur in response to cross-coupled 
motion, translational motion, off vertical axis rotation 
(OVAR), etc. Eyestrain can be more common with visually 
induced motion sickness (VIMS), but can still occur with 
classic ‘motion sickness. At lower levels of sickness, the SSQ is 
arguably more sensitive than simply asking about nausea and 
stomach awareness. There was also an additional item on 
vomiting. Other questions concerned use of any medical 
treatments, including antimotion sickness drugs. Finally, 
from the ship’s plans of the Astrolabe, the distance of each pas-
senger’s cabin to the Centre of Gravity (CoG) of the vessel was 
calculated to determine whether this distance was an influ-
ence on symptoms, a topic of debate in the literature.6
Statistical Analysis:
The statistical analysis was carried out with IBM SPSS statistics 
v 25.0. The methods used were descriptives, correlational anal-
ysis, multiple linear regression, ANOVA, and Student t-tests. In 
ANOVA, factor labels were: Days (voyage days from day 0 to 
day 6), Trip direction (out from Hobart vs. return from Antarc-
tica). All tests of significance were two-tailed.
RESULTS
Descriptives are presented in Table I. Subjects in this study were 
less susceptible to motion sickness than the general population, 
with MSSQ percentile scores (mean ± SD) 37.4 ± 28.3, where 
the norm in the general population is 50 by definition (compar-
ison with norm 50, 1-sample test, t = 6.81, df 233, P < 0.001, 
2-tailed). Three crewmembers were included in the study. 
Crewmembers were already experienced in these types of 
rough conditions but we could not extract a subgroup of the 
few crewmembers recruited, since the survey was anonymous 
by intention.
The most common antimotion sickness medications used 
were scopolamine (patch or tablets) (25.5%), antihistamines 
(19.7%), scopolamine and antihistamine (8%), and domperi-
done (one person, less than 1%). Of passengers, 46% did not 
take any drug. Drugs were predominantly self-administered 
and often after the onset of symptoms. Some people took a sco-
polamine patch the first day of the trip or during the trip but 
not preventively the days before. It was notable that those who 
took antimotion sickness medications were more likely to think 
they might become sick (Chi-squared = 6.97, df 1, P < 0.01, 
2-tailed) and had significantly greater susceptibility to motion 
sickness as revealed by their higher mean MSSQ percentile 
scores (used antimotion sickness drug: 44.4 + 28.2 vs. no drug: 
29.4 + 26.3; independent t-test t = 4.17, df 232, P < 0.001, 
2-tailed).
Trip direction appeared to be a factor in the evolution of 
motion sickness during the voyages. The peak for motion sick-
ness occurred shortly after leaving port in Hobart on outward 
voyages. By contrast the peak for motion sickness was more 
delayed when considering voyages returning from Antarctica. 
This is shown in Fig. 2. ANOVA showed no overall significant 
differences in degree of motion sickness in terms of trip direc-
tion. However, there were significant effects for time (Days) and 
interaction Days × Trip direction (ANOVA: Days: F = 12.50, df 
6, 672, P < 0.001; Trip-direction: F = 1.53, df 1112, P = ns; Days 
× Trip-direction: F = 8.83, df 6, 672, P < 0.001). The effect for 
Days simply reflected the onset of peak sickness followed by a 
decrease (probably due to habituation). The Days × Trip 
Direction interaction was due to the different timing of peak 
sickness in terms of trip direction (see Fig. 2).
Fig. 2. Motion sickness peaks earlier on Outward voyages than Return 
voyages due to different sea conditions. High sea states are encountered 
early after leaving port in the outward voyages. By contrast Antarctic pack 
ice in the early part of return voyages produces relatively calmer sea states 
and less seasickness early on. See text for more details.
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For the correlation analysis of the different variables, the 
Simulator Sickness Questionnaire (SSQ) mean score over 
days 0–6 was used as the measure of averaged Seasickness. 
Other analyses (not given for brevity) were performed using 
various other measures of motion sickness. These included 
peak sickness, mid-voyage sickness averages, nausea alone 
ratings, subscales of the SSQ, total vomiting episodes, possible 
habituation slope angles after peak sickness, etc. However, 
they added no obvious advantage nor gave any additional 
insights as measure of motion sickness compared with the 
averaged SSQ mean score over the whole voyage days 0–6. 
There was a good correlation between the average number of 
times that a person vomited over the whole voyage days 0–6 
and the SSQ mean score over days 0–6 (r = 0.58, P < 0.001). 
The averaged SSQ measure also had the advantage of captur-
ing the greatest amount of data concerning level of motion 
sickness in a single variable for subsequent analyses. 
Correlations of selected variables with the SSQ are summa-
rized in Table II. The main variables associated with greater sea-
sickness were: greater initial motion sickness sensitivity 
(MSSQ), anticipation of being ill, younger age, further dis-
tance between the CoG of the boat to the cabin, and higher 
level of anxiety, especially at midtrip. The strongest associa-
tion of seasickness was with the MSSQ shown as scatterplot in 
Fig. 3A. The use of antimotion sickness medication was associ-
ated with greater levels of motion sickness.
The distance of the cabin from the vessel’s CoG was signifi-
cantly correlated with the average intensity of the symptoms 
during the crossing (see Table II and Fig. 3B). A specific analy-
sis of the symptoms according to the axis of the berth in relation 
to the structure of the vessel did not reveal any significant dif-
ference between the upper and lower berth positions, nor was 
there any obvious relationship with orientation of bunks to 
ship axis.
Multiple linear regression was employed to predict 
motion sickness (SSQ averaged over days 0–6) as the depen-
dent variable. All the variables shown in Table II were entered 
as possible predictors, together with another variable 
(binary) Trip Direction. It could be argued that variables 
such as state anxiety during the voyages should be omitted 
since they seem to be a consequence or cause of motion sick-
ness rather than a cause, and they are not what might be 
termed baseline ‘predictors.’ However, they were entered 
simply for completeness of a possible model. This initial 
analysis produced a significant model (adjusted R square = 
0.25, ANOVA F = 4.75, df 11,113, P < 0.001). Higher MSSQ 
was a significant predictor with greater cabin distance to CoG 
and older age being marginal predictors. All other predictors 
failed significance. A simplified multiple regression was then 
run, entering only the predictors MSSQ, cabin distance and 
age which produced a significant model and similar results 
(Multiple R = 0.53, raw R square = 0.28, adjusted R square = 
0.26, ANOVA F = 16.33, df 3126, P < 0.001). The predictor 
weightings were in decreasing order MSSQ (beta = 0.48, P < 
0.001), greater cabin distance to CoG (beta = 0.21, P < 0.01), 
older age (beta = −0.18, P < 0.05) (i.e., negative loading direc-
tion so the younger are more sick). This simplified regression 
model is shown in Fig. 3C. A variety of other regression mod-
els were employed including stepwise, but these did not alter 
the main conclusions above. The reason for the fact that some 
variables (anxiety, expectancy to be sick) which showed sig-
nificant bivariate correlations with motion sickness (see Table 
II) dropped out from the multivariate analysis was doubtless 
due to collinearity, as revealed by inspection of the whole cor-
relation matrix (for brevity not shown). For example, 
‘Expectancy to be Sick’ significantly correlated with MSSQ, 
but MSSQ was the better predictor of motion sickness.
Lastly, we examined the previously identified baseline vari-
ables and concluded that the best practical combination was the 
question (Do you think you’ll be sick) and MSSQ. Both param-
eters helped us to establish three groups of susceptibility to 
motion sickness onboard Astrolabe. Each susceptibility group 
was determined based on its mean SSQ score for the entire 
crossing (mean SSQ days 0–6). None of these factors, applied 
alone, resulted in three significantly different groups, conse-
quently, two predictive factors were applied in combination: 
“Do you think you will be sick during the crossing” and the 
MSSQ score. To the question: “Do you think you will be sick 
during the crossing?”, 164 responded “YES,” 53 “NO,” and 22 
“DON’T KNOW” (DK). These groups were not significantly 
different from each other, but the average of SSQ for the DK 
group was close to that of the YES group. The group that did 
not know if they were going to be ill was therefore included in 
the group that thought they would be ill. We then applied the 
MSSQ variable to obtain three groups. Passengers who thought 
they would be sick during the crossing (YES) were arbitrary 
and empirically separated into two groups: group 1 with pas-
sengers with a MSSQ score greater than 10 and group 2 with 
passengers with a MSSQ score less than 10. For the NO group, 
passengers with a MSSQ score greater than 15 were allocated to 
group 2 and those with a MSSQ score less than 15 were allo-
cated to group 3. This distribution made it possible to obtain 
three groups that were significantly different from each other 
regarding the intensity of their symptoms during the crossing 
(average SSQ Day 0–6). One-way ANOVA between the three 
groups, with averaged SSQ as the measure of motion sickness, 
was significant (F= 14.42, df 2,209, P < 0.001), with post-hoc 
testing showed that each of the 3 groups were significantly dif-
ferent from one another (P < 0.05 to P < 0.001).
Table II. Correlations of Selected Variables with Simulator Sickness 
Questionnaire (SSQ) Mean Score Over Days 0–6 as Measure of Averaged 
Motion Sickness.
VARIABLE R P VARIABLE R P
Age −0.13 * Anxiety Trait 0.12 ns
Gender 0.06 ns Anxiety Begin 0.20 **
Past Trips −0.06 ns Anxiety Midtrip 0.39 ***
Expect Sick 0.24 *** Anxiety End 0.26 ***
MSSQ Total 0.37 *** Cabin Dist. CoG 0.23 ***
Drug Anti-MS 0.23 ***
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DISCUSSION
A major finding of our study was that 94% of passengers suf-
fered at least from one symptom of motion sickness at some 
stage and up to 40% of them vomited. The SSQ score, taken as 
the measure of motion sickness, was maximal one day after 
departure for the outward trip and on day 3 for the return trip. 
The maximum score for the outward trip was higher than the 
Fig. 3. Scatterplot representing the correlation between the level of sea-sickness (SSQ) and the susceptibility of MS (MSSQ) (3A), the influence of the 
distance of the cabin from the center of gravity (in meters) on the average symptoms during the crossing (3B). A simplified Multiple Linear Regression Model 
is shown (3C) where higher MSSQ, greater Cabin distance to CoG and younger Age, predict more Motion Sickness (SSQ score averaged over voyage days 0–6). 
The dotted lines indicate 95% Cis.
MOTION SICKNESS—Besnard et al.
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maximum score for the return trip but overall sickness was not 
significantly higher. Five associated factors for seasickness were 
observed: higher intrinsic individual motion sickness suscepti-
bility (MSSQ), younger age, higher level of anxiety at midtrip, 
greater anticipation of being, and longer distance between the 
CoG and the cabin. An algorithm including two of these 
parameters (MSSQ, and a question “Do you think you’ll be 
sick”) may help to define people at high risk of motion sickness 
on Astrolabe in order to better allocate preventative actions.
The population included in this study was less susceptible to 
motion sickness than the general population (37.4 percentile 
instead of 50) according to normative data.7,18 This characteris-
tic is found for passengers on scientific parabolic flights9 and 
can be explained by similar factors here. A natural self-selection 
bias is doubtless related to the fact that people who are highly 
sensitive to motion sickness are unlikely to engage in a research 
project that requires a trip in very rough conditions. In addi-
tion, the population is predominantly male and of average age 
around 40 yr rather than younger, both of which can reduce 
susceptibility to motion sickness.7
Ninety-four percent of passengers experienced at least one 
symptom of motion sickness despite being an already low sus-
ceptibility group. This doubtless reflects the very difficult sea 
conditions encountered. Gahlinger et al.6 reported a prevalence 
of 74% during the first 2–3 d of the sea crossing to Antarctica, 
however the threshold of having been sick was not precisely 
explained nor the boat specifications (flat-bottom or not). A 
difference between travel directions was noted in our study. 
The maximum SSQ score, reflecting the intensity of motion 
sickness, is reached in the first 24 h after departure from Hobart 
in Australia, whereas it is lower and then progressively maximal 
on day 3 after departure from Dumont d’Urville in Antartica. 
The day 0 score corresponds to the assessment made on the 
first day at the beginning of the crossing and measurement 
depends on the time of the boat’s departure in the morning or 
in the evening. Thus, the Day 1 score is achieved after the first 
night, i.e., between 10 and 24 h after the start of the trip. The 
maximum motion sickness at the beginning of the crossing 
from Hobart may be due to various factors: the emotional fac-
tor of fear of a first rough crossing, the initial fatigue of passen-
gers who accumulate about 30 h of air travel with little sleep, 
(sleep deprivation is known to worsen motion sickness and 
slow habituation14), the time difference of 10 h from Europe 
and those who board on arrival or the next day, the immediate 
rough sea condition after passing the Gulf of Hobart. All these 
factors can explain the high level of motion sickness, without 
prior maritime experience to provide any protective adaptation, 
with little information and medications often taken too late at 
the beginning of the crossing or after the first symptoms 
occurred. Motion sickness was somewhat lower (below signifi-
cance overall) during the return trip with a maximum at day 3 
which can be explained by less tiredness (absence of jet lag and 
acclimatization with better quality sleep on the Durmont d’Ur-
ville base), the absence of first crossing effects, and often a first 
day of the trip in calm seas during crossing the ice zone on the 
outward passage from Antarctica.
The most common antimotion sickness medications used 
were scopolamine (patch or tablets) and antihistamines. These 
were predominantly self-administered. Surprisingly, the inci-
dence of seasickness was greater in those reporting use of 
antimotion sickness drugs. Over 30 yr ago Lawther and 
Griffin17 made an identical observation on very large surveys of 
sea passengers which contributed to the ISO engineering stan-
dard for motion sickness (ISO, 1997). They conjectured “…that 
people who know that they are susceptible to seasickness take 
medication more readily….”17 Unfortunately, they had no evi-
dence to support their conjecture. Herein, the present study 
solves their lack of supporting evidence since it showed that 
those who took antimotion sickness medication were signifi-
cantly higher in intrinsic motion sickness susceptibility as 
revealed by the MSSQ, and also were aware of this at baseline 
since they were more likely to think they might become seasick. 
No drugs were preventively taken on board before the begin-
ning of the trip and no recommendation went in that direction. 
Moreover, drug intake could not be controlled in this observa-
tional study since it was delivered on request by the passengers 
according to the appearance of clinical symptoms throughout 
the trip. We did not aim to perform a pharmacological study 
comparing the efficiency of each drug.
One interesting point is related to the habituation process 
since, whatever the direction of the crossing, and even at the 
end of the return trip where the sea is rougher up to Hobart, the 
SSQ score decreased over the last 3 d to reach its minimum on 
the last day. Habituation is a phenomenon reported at sea,22 for 
pilots,11 and passengers on parabolic flights5 where repeated 
exposure reduces motion sickness and is equivalent to desensi-
tization. The underlying neurophysiological mechanism 
remains debated and can be played out at different brain stages: 
1) brain stem with an adaptation of the time constant of storage 
of head movement velocity; and 2) the temporal-parietal multi-
sensory cortex with a reweighting mechanism by a change in 
preference for the use of a sensory modality.5 A role for tempo-
ral resynchronization of visuo-vestibular information at the 
cerebral cortex has also been suggested.20 Emotional compo-
nents may also be involved in the habituation observed here, 
i.e., the arrival in Antarctica in the ice or the return to Hobart 
and to the civilization, which represent two contexts where 
emotion and the desire to arrive induce positive feelings in pas-
sengers. Although the emotional effect on motion sickness is 
poorly documented,1,16 an interaction between the visuo-ves-
tibular system and the emotional system is reported4,12 and may 
play a role in reducing or increasing motion sickness.
Variables predicting motion sickness were identified in this 
study using multi linear regression analysis: higher MSSQ sus-
ceptibility test score, longer distance of the cabin from the CoG of 
the ship, and younger age. Higher susceptibility and younger age 
are in agreement with the data in the literature.24 However, age 
was a weak predictor of MS despite statistical significance. The 
relatively weak influence of age in this study was perhaps because 
of insufficient numbers of very old and of very young people, 
resulting in a statistical range restriction effect. Expectancy to be 
sick and anxiety, which both had significant bivariate correlations 
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with sea sickness, were not significant predictors in the mutiple 
linear regression model, perhaps due to collinearity. The influ-
ence of gender on motion sickness, which is a frequently reported 
factor, was not demonstrated here as a predictive factor in our 
study, perhaps reflecting the fact that our sample was more than 
2/3 male, minimizing the gender effect.
The influence of cabin position on motion sickness is still 
debated in the literature. We found that the axis of the beds in 
relation to the axis of the boat had no influence on the symptoms. 
The same was true between the upper berth and the lower berth. 
On the other hand, passengers with the cabins furthest away from 
the center of gravity of the boat were the sickest during the cross-
ing. Several studies on this point have been published with con-
tradictory findings: for example, the U.S. Navy reported no 
association between cabin position and symptoms.2 The influ-
ence of swell on motion sickness is mainly related to vertical accel-
eration. But pitching motion of a boat also produces a translational 
component which is experienced at locations away from the cen-
ter of rotation, which is usually the center of gravity of the vessel. 
Logic dictates that the cabins furthest from the center of gravity 
suffer the most from pitching and consequent translational 
motion. This is evidenced by the English Channel Ferry study.17 It 
was based on data from 5000 passengers and showed a strong 
association between passenger location and symptoms. However, 
a more recent study on very large cruise liners found no such 
association.6 One explanation for the contradictions between 
studies is that the position of the cabin may have an influence on 
motion sickness that is greater for smaller ships, such as in our 
study. Accelerometric tools were available in the bridge of the 
Astrolabe measuring boat motion in real-time helping navigation 
and safety, but are not recorded. Unfortunately, an accelerometer 
with a recording module placed on board in one of the cabins suf-
fered from shaking during each trip with data losses which did 
not allow meaningful analysis. However, in view of the strength of 
the correlation, we included the position of the cabins in our rec-
ommendation guide in order to adapt the distribution of the cab-
ins for the passengers according to their susceptibility. This is in 
fact what is done by major shipping companies where cabins in 
the middle of the vessel are often more expensive than others.6
We developed an algorithm with a decision tree from two 
associated factors (question: “do you think you will be ill on 
board the Astrolabe?”; and the MSSQ with two threshold val-
ues at 10 and 15). The 10 and 15 thresholds were empirically 
chosen as a good level of discrimination. This also fit with the 
3 main groupings of cabin positions from CoG for allocating 
predicted risk groups. We used the most important potential 
baseline correlates of motion sickness as predictors and simpli-
fied it to two predictors: “Do you think you will be sick?” and 
the MSSQ. The algorithm quickly and easily scored passengers 
to define three susceptibility groups (low, medium, high), in 
particular the passenger group most at risk. These thresholds 
might be adjusted in the future following cumulative data 
recording. This screening could help to better prepare future 
passengers of the Astrolabe by proposing a more targeted and 
efficient countermeasure for each one. For example, to pro-
pose desensitization to motion sickness19,23 before departure 
combined with placement in the cabins closest to the center of 
gravity and pharmacological and nonpharmacological thera-
peutic care throughout the crossing with the on-board doctor.
In conclusion, this study showed a very high prevalence of 
motion sickness for passengers despite their low intrinsic sensitiv-
ity to motion sickness, on a specific boat in the harsh conditions of 
the Southern Ocean. Five factors associated with sea sickness 
were identified and a decision algorithm based on two factors was 
developed which should allow a better screening of the future pas-
sengers most at risk, to improve their management.
Our observations concerning the effects of antimotion sick-
ness drugs and length of and direction of voyage on motion sick-
ness were preliminary and informal because we had no control 
over the timing and dosage of the antimotion sickness drugs 
(some were taken before and some after onset of motion sick-
ness symptoms) and no data concerning the day-to-day acceler-
ations of the ship. Those who took antimotion sickness drugs 
were more likely to have both higher MSSQ and SSQ scores, 
suggesting a greater initial susceptibility to motion sickness in 
those taking the antimotion sickness drugs. Motion sickness rat-
ings were higher on the outbound direction and, correspond-
ingly in the earlier days of the voyage, but more formal research 
is needed to evaluate the significance of these effects.
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